Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of MediGene patents

Patents where

Current Assignee

Name

MediGene

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9770406 Medicament for the treatment of viral skin and tumour diseases	Patent 9770406 was granted and assigned to MediGene on September, 2017 by the United States Patent and Trademark Office.		MediGene	United States Patent and Trademark Office	9770406	September 26, 2017
‌ US Patent 7618452 Artificially produced, three-dimensional muscle tissue	Patent 7618452 was granted and assigned to MediGene on November, 2009 by the United States Patent and Trademark Office.		MediGene	United States Patent and Trademark Office	7618452	November 17, 2009
‌ US Patent 7329731 Soluble T cell receptor	Patent 7329731 was granted and assigned to MediGene on February, 2008 by the United States Patent and Trademark Office.		MediGene	United States Patent and Trademark Office	7329731	February 12, 2008
‌ US Patent 7425339 CD8alpha mutants	Patent 7425339 was granted and assigned to MediGene on September, 2008 by the United States Patent and Trademark Office.		MediGene	United States Patent and Trademark Office	7425339	September 16, 2008
‌ US Patent 7252997 Structural protein of adeno-associated virus with modified antigenicity, its production and its use	Patent 7252997 was granted and assigned to MediGene on August, 2007 by the United States Patent and Trademark Office.		MediGene	United States Patent and Trademark Office	7252997	August 7, 2007
‌ US Patent 9821043 Anti-HER2 vaccine based upon AAV derived multimeric structures	Patent 9821043 was granted and assigned to MediGene on November, 2017 by the United States Patent and Trademark Office.		MediGene	United States Patent and Trademark Office	9821043	November 21, 2017
‌ US Patent 9238021 Method of producing a cationic liposomal preparation comprising a lipophilic compound	Patent 9238021 was granted and assigned to MediGene on January, 2016 by the United States Patent and Trademark Office.	MediGene	MediGene	United States Patent and Trademark Office	9238021	January 19, 2016
‌ US Patent 8663606 Method of producing a cationic liposomal preparation comprising a lipophilic compound	Patent 8663606 was granted and assigned to MediGene on March, 2014 by the United States Patent and Trademark Office.		MediGene	United States Patent and Trademark Office	8663606	March 4, 2014
‌ US Patent 7001765 Adeno-associated virus vector for boosting immunogenicity of cells	Patent 7001765 was granted and assigned to MediGene on February, 2006 by the United States Patent and Trademark Office.		MediGene	United States Patent and Trademark Office	7001765	February 21, 2006
‌ US Patent 7968340 Structural protein of adeno-associated virus with modified antigenicity, its production and its use	Patent 7968340 was granted and assigned to MediGene on June, 2011 by the United States Patent and Trademark Office.		MediGene	United States Patent and Trademark Office	7968340	June 28, 2011
‌ US Patent 9060998 Use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin	Patent 9060998 was granted and assigned to MediGene on June, 2015 by the United States Patent and Trademark Office.	MediGene	MediGene	United States Patent and Trademark Office	9060998	June 23, 2015
‌ US Patent 8168216 Treatment of triple receptor negative breast cancer	Patent 8168216 was granted and assigned to MediGene on May, 2012 by the United States Patent and Trademark Office.		MediGene	United States Patent and Trademark Office	8168216	May 1, 2012
‌ US Patent 8455022 Use of a polyphenol for the treatment of a cancerous or precancerous lesion of the skin	Patent 8455022 was granted and assigned to MediGene on June, 2013 by the United States Patent and Trademark Office.		MediGene	United States Patent and Trademark Office	8455022	June 4, 2013
‌ US Patent 7910138 Use of a polyphenol for the treatment of a cancerous or precancerous lesion of the skin	Patent 7910138 was granted and assigned to MediGene on March, 2011 by the United States Patent and Trademark Office.		MediGene	United States Patent and Trademark Office	7910138	March 22, 2011
‌ US Patent 9144563 Treatment of triple receptor negative breast cancer	Patent 9144563 was granted and assigned to MediGene on September, 2015 by the United States Patent and Trademark Office.		MediGene	United States Patent and Trademark Office	9144563	September 29, 2015
‌ US Patent 7556965 Structural protein of adeno-associated virus with modified antigenicity, its production and its use	Patent 7556965 was granted and assigned to MediGene on July, 2009 by the United States Patent and Trademark Office.		MediGene	United States Patent and Trademark Office	7556965	July 7, 2009
‌ US Patent 7932253 Immunomodulating oxopyrrazolocinnolines as CD80 inhibitors	Patent 7932253 was granted and assigned to MediGene on April, 2011 by the United States Patent and Trademark Office.		MediGene	United States Patent and Trademark Office	7932253	April 26, 2011
‌ US Patent 7494658 Papilloma virus truncated L1 protein and fusion protein constructs	Patent 7494658 was granted and assigned to MediGene on February, 2009 by the United States Patent and Trademark Office.		MediGene	United States Patent and Trademark Office	7494658	February 24, 2009
‌ US Patent 7182947 Papillomavirus truncated L1 protein and fusion protein constructs	Patent 7182947 was granted and assigned to MediGene on February, 2007 by the United States Patent and Trademark Office.		MediGene	United States Patent and Trademark Office	7182947	February 27, 2007
‌ US Patent 9233094 Method of administering a cationic liposomal preparation	Patent 9233094 was granted and assigned to MediGene on January, 2016 by the United States Patent and Trademark Office.		MediGene	United States Patent and Trademark Office	9233094	January 12, 2016
‌ US Patent 8075913 Method of producing a cationic liposomal preparation comprising a lipophilic compound	Patent 8075913 was granted and assigned to MediGene on December, 2011 by the United States Patent and Trademark Office.		MediGene	United States Patent and Trademark Office	8075913	December 13, 2011
‌ US Patent 7858662 Medicament for the treatment of viral skin and tumour diseases	Patent 7858662 was granted and assigned to MediGene on December, 2010 by the United States Patent and Trademark Office.		MediGene	United States Patent and Trademark Office	7858662	December 28, 2010
‌ US Patent 7598247 Immunomodulating heterocyclic compounds	Patent 7598247 was granted and assigned to MediGene on October, 2009 by the United States Patent and Trademark Office.		MediGene	United States Patent and Trademark Office	7598247	October 6, 2009
‌ US Patent 8163757 Immuno inhibitory pyrazolone compounds	Patent 8163757 was granted and assigned to MediGene on April, 2012 by the United States Patent and Trademark Office.		MediGene	United States Patent and Trademark Office	8163757	April 24, 2012
‌ US Patent 8092807 Modified leukocyte Ig-like receptor family members (LIRs) with increased affinity for class 1 MHC and their uses in modulating T-cell activation	Patent 8092807 was granted and assigned to MediGene on January, 2012 by the United States Patent and Trademark Office.		MediGene	United States Patent and Trademark Office	8092807	January 10, 2012

Results per page:

27 results

0 selected

27 results

0 selected